REVOLUTION MEDICINES INC (1RVMD.MI) Stock Price & Overview
BIT:1RVMD • US76155X1000
Current stock price
The current stock price of 1RVMD.MI is 83 EUR. Today 1RVMD.MI is down by -17%.
1RVMD.MI Key Statistics
- Market Cap
- 16.046B
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -4.38
- Dividend Yield
- N/A
1RVMD.MI Stock Performance
1RVMD.MI Stock Chart
1RVMD.MI Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to 1RVMD.MI.
1RVMD.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to 1RVMD.MI. While 1RVMD.MI seems to be doing ok healthwise, there are quite some concerns on its profitability.
1RVMD.MI Earnings
1RVMD.MI Forecast & Estimates
27 analysts have analysed 1RVMD.MI and the average price target is 100.64 EUR. This implies a price increase of 21.25% is expected in the next year compared to the current price of 83.
For the next year, analysts expect an EPS growth of -59.94% and a revenue growth 1279.08% for 1RVMD.MI
1RVMD.MI Groups
Sector & Classification
1RVMD.MI Financial Highlights
Over the last trailing twelve months 1RVMD.MI reported a non-GAAP Earnings per Share(EPS) of -4.38. The EPS decreased by -44.01% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -26.65% | ||
| ROE | -37.58% | ||
| Debt/Equity | 0.16 |
1RVMD.MI Ownership
1RVMD.MI Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ARGX | ARGENX SE | 26.79 | 40.049B | ||
| 1AE | ARGENX SE | 26.69 | 39.987B | ||
| 22UA | BIONTECH SE-ADR | N/A | 20.44B | ||
| 2X1 | ABIVAX SA | N/A | 8.044B | ||
| ABVX | ABIVAX SA | N/A | 8.028B | ||
| GXE | GALAPAGOS NV | N/A | 1.691B | ||
| GLPG | GALAPAGOS NV | N/A | 1.687B | ||
| NANO | NANOBIOTIX | N/A | 1.326B | ||
| DBV | DBV TECHNOLOGIES SA | N/A | 1.012B | ||
| PHGN | PHARMING GROUP NV | 41.99 | 1.011B | ||
| PHARM | PHARMING GROUP NV | 41.23 | 1.005B | ||
| 6IV | INVENTIVA SA | N/A | 981.43M | ||
| IVA | INVENTIVA SA | N/A | 980.391M |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Milan Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About 1RVMD.MI
Company Profile
Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. The company is headquartered in Redwood City, California and currently employs 809 full-time employees. The company went IPO on 2020-02-13. The Company’s research and development pipeline comprises RAS(ON) inhibitors that bind directly to RAS variants, which it refers to as RAS(ON) Inhibitors, and RAS companion inhibitors that target key nodes in the RAS pathway or associated pathways, which it refers to as RAS Companion Inhibitors. Its RAS(ON) Inhibitors are designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or in combination with RAS Companion Inhibitors or other therapeutic agents. The company’s RAS(ON) inhibitors are daraxonrasib (RMC-6236), an RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), an RAS(ON) G12C-selective inhibitor; and zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor, are in clinical development. The Company’s pipeline also focuses on RAS(ON) mutant-selective inhibitors, including RMC-0708 (Q61H) and RMC-8839 (G13C).
Company Info
IPO: 2020-02-13
REVOLUTION MEDICINES INC
700 Saginaw Dr
Redwood City CALIFORNIA US
Employees: 809
Phone: 13026365400
REVOLUTION MEDICINES INC / 1RVMD.MI FAQ
What does REVOLUTION MEDICINES INC do?
Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. The company is headquartered in Redwood City, California and currently employs 809 full-time employees. The company went IPO on 2020-02-13. The Company’s research and development pipeline comprises RAS(ON) inhibitors that bind directly to RAS variants, which it refers to as RAS(ON) Inhibitors, and RAS companion inhibitors that target key nodes in the RAS pathway or associated pathways, which it refers to as RAS Companion Inhibitors. Its RAS(ON) Inhibitors are designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or in combination with RAS Companion Inhibitors or other therapeutic agents. The company’s RAS(ON) inhibitors are daraxonrasib (RMC-6236), an RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), an RAS(ON) G12C-selective inhibitor; and zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor, are in clinical development. The Company’s pipeline also focuses on RAS(ON) mutant-selective inhibitors, including RMC-0708 (Q61H) and RMC-8839 (G13C).
What is the current price of 1RVMD stock?
The current stock price of 1RVMD.MI is 83 EUR. The price decreased by -17% in the last trading session.
Does 1RVMD stock pay dividends?
1RVMD.MI does not pay a dividend.
How is the ChartMill rating for REVOLUTION MEDICINES INC?
1RVMD.MI has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What is the employee count for 1RVMD stock?
REVOLUTION MEDICINES INC (1RVMD.MI) currently has 809 employees.
What is REVOLUTION MEDICINES INC worth?
REVOLUTION MEDICINES INC (1RVMD.MI) has a market capitalization of 16.05B EUR. This makes 1RVMD.MI a Large Cap stock.